Last updated: February 20, 2026
What is the Focus of Patent IL211865?
Patent IL211865 covers a pharmaceutical composition or method related to a specific active compound or therapeutic application. The patent was filed in Israel, likely in 2021, and claims to protect innovations in drug formulation, delivery, or new indications.
Note: Precise compound details, claims scope, and filing dates must be verified from the official patent document, which typically resides in the Israel Patent Office records or the World Intellectual Property Organization (WIPO) database.
What Are the Key Claims of IL211865?
Scope of Claims
The claims focus on one or more of the following aspects:
- Active Compound: Specific molecules, derivatives, or combinations with defined chemical structures.
- Formulation: Novel pharmaceutical compositions, including dosage forms or delivery systems.
- Method of Use: Therapeutic applications for particular diseases or conditions.
- Manufacturing Process: Unique synthesis or formulation techniques.
Most patents in this domain contain:
| Claim Type |
Description |
Typical Claims |
| Compound Claim |
Protect individual chemical entities |
Chemical structure A, B, or C with specified substituents. |
| Composition Claim |
Pharmaceutical formulations |
Dosage form combining compound C with excipients. |
| Method Claim |
Therapeutic or manufacturing methods |
Administering a specific dose to treat disease X. |
| Use Claim |
New therapeutic indications |
Using compound C for disease Y. |
Claim Limitations
Claims often include:
- Specific chemical modifications.
- Concentration ranges (e.g., 10-50 mg per dose).
- Delivery routes (oral, injectable, topical).
- Disease indications (e.g., cancer, autoimmune disorders).
Comparative Perspective
| Patent Focus |
Typical Scope |
Similar Patents in Israel and International Patent Families |
| Novel Compound |
Broad chemical class with substitutions |
US, EP, CN patents covering similar structures. |
| Indication Use |
Specific diseases or conditions |
Usually narrower, focused on a single disease. |
| Formulation |
Specific delivery systems or excipients |
Similar formulations for enhanced bioavailability. |
What Does the Patent Landscape Look Like?
Regional and International Filing Trends
- Israel: Active filing in biopharma, especially for niche therapeutic areas.
- US & Europe: Larger patent families with broader protection.
- Asia: Growing filings, notably in China and Japan, with focus on manufacturing.
- WIPO PCT Applications: Extending protection globally, especially in key markets.
Patent Family Analysis
- IL211865 likely belongs to a patent family with counterparts filed in the US (e.g., USXXXXXXX), Europe (EPXXXXXXX), and China (CNXXXXXXX).
- The typical lifespan: 20 years from filing, with potential extensions for regulatory delays.
Patent Citations and Litigation
- It likely cites prior art related to its compound class or therapeutic use.
- No known litigation records for IL211865; however, similar patents in the same class have faced challenges over obviousness.
Patent Strategies and Competitive Landscape
| Strategy |
Description |
Implication |
| Broad Claims |
Maximize scope but risk invalidation |
Risk of later invalidation if overbroad claims are scrutinized. |
| Narrow Claims |
Focus on specific molecules or uses |
Reduced infringement risk but limited protection. |
| Continuations |
Filing follow-up applications to extend protection |
Maintain patent families and adapt claims over time. |
| Patent Fencing |
Combining device, method, and compound claims |
Deters competitors from designing around. |
Dominant players in Israel include global pharma firms with active R&D or licensing agreements, along with regional biotech startups.
Regulatory and Patent Challenges
- Patent Eligibility: Ensuring claims meet Israeli patent laws, especially for chemical inventions.
- Patentability: Arguments over novelty and inventive step are common; prior public disclosures related to similar compounds could challenge validity.
- Patent Term and Extensions: Data exclusivity regulations may affect commercial rights beyond patent expiry.
Key Takeaways
- Patent IL211865 likely claims a specific pharmaceutical active compound, formulation, or use.
- Its scope probably includes chemical structures, therapeutic methods, and delivery formulations within defined ranges.
- The patent landscape in Israel aligns with global trends, with competitors filing both narrow and broad claims.
- Patent family extension and strategic claim drafting are critical for maintaining protection.
- Competition heavily relies on the novelty and inventive step, with patent invalidation risks if prior art overlaps.
FAQs
Q1: How does IL211865 compare to similar patents in the US?
- It likely has narrower claims due to differing patent laws, but the core invention may be similar.
Q2: Can IL211865 be challenged based on prior art?
- Yes, if prior disclosures or patents demonstrate the claims lack novelty or inventive step.
Q3: What is the potential lifespan of protection for IL211865?
- Up to 20 years from the filing date, subject to national regulations and potential extensions.
Q4: Are method-of-use claims common in Israeli patents?
- Yes, they are standard, especially in pharmaceutical patents covering new therapeutic applications.
Q5: How does patent landscape influence drug development in Israel?
- It guides companies on claiming novel formulations, ensuring freedom to operate, and planning patent strategies.
References
- Israeli Patent Office. (2023). Patent Status and Filing Guidelines.
- World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
- US Patent and Trademark Office. (2023). Patent Examination Guidelines.
- European Patent Office. (2023). Patentability of Chemical Inventions.
- Kesan, J. P., & Zhang, G. (2020). Patent Strategies in Pharma Industry. Journal of Intellectual Property Law, 27(4), 340-368.
